Jot Dx™ Insertable Cardiac Monitor (ICM) is the latest medical technology advancement only from Abbott that helps people get back to living their best lives, faster.
Jot Dx ICM is powered by SyncUP™ - a concierge service, provided by Abbott that helps patients get connected to the myMerlin™ mobile app so that data is automatically sent to your clinic.
Select between three key episodes* or all episode data and so that you can get precise and actionable data without feeling overwhelmed by data burden.
Flexibilty to match the needs of your clinic or individual patients.
Discover what Jot Dx has to offer by watching our short video below
For hard-to-detect arrhythmias you can toggle to view all episodes for a specific patient, rather than three key episodes. You can also view all episodes facility-wide.
Key episodes are uniquely programmed to evaluate each arrhythmia differently: AFib, Tachy, Brady and Pause each have a novel set of evaluation criteria that make up the three key episodes. This ensures you receive the most insightful data based on arrhythmia type.
Better selection criteria sets Jot Dx ICM apart from others that use a standard set of criteria for all types.
Even with three key episodes turned on, there is no loss of accuracy, and virtually no delay-to-diagnosis.2
Jot Dx ICM with SharpSense™ technology improves accuracy of all episodes by harnessing the power of extra discriminators to confirm or reject detections – significantly improving the accuracy of Atrial Fibrillation, Bradycardia and Pause detected episodes.
Retrospective analysis of a Global Registry demonstrates SharpSense™ technology significantly reduces false detection of AFib, Bradycardia and Pause episodes.
Jot Dx ICM with SharpSense™ technology improves accuracy of all episodes by harnessing the power of extra discriminators to confirm or reject detections – significantly improving the accuracy of Atrial Fibrillation, Bradycardia and Pause detected episodes.
Retrospective analysis of a Global Registry demonstrates SharpSense™ technology significantly reduces false detection of AFib, Bradycardia and Pause episodes.
References
*Key episodes is a feature of Merlin.net™
**Determined by evaluation of real-world episodes in previously identified devices, using SharpSense™ technology.
™ Indicates a trademark of the Abbott group of companies.
‡ Indicates a third-party trademark, which is property of its respective owner.
MAT-2108290 v3.0
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?
MAT-2305078 v1.0
